Simplex Trading’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-53,300
Closed -$655K 10665
2022
Q4
$655K Buy
53,300
+49,800
+1,423% +$1.19M ﹤0.01% 2905
2022
Q3
$114K Buy
+3,500
New +$98.9K ﹤0.01% 5348

Simplex Trading's CINC Position: Q1 2023 in Review

Simplex Trading sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 24,905 shares — an estimated $306K sold.

Simplex Trading first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $306K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Simplex Trading reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 24,905 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $306K.
  • Simplex Trading first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Simplex Trading's CinCor Pharma, Inc. Common Stock position peaked at $306K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.